Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 30, 2025 4
4 May 30, 2025 4
4 May 30, 2025 4
3 May 30, 2025 3
SCHEDULE 13G May 15, 2025
10-Q May 13, 2025 10-Q
8-K May 13, 2025 8-K
SCHEDULE 13G May 9, 2025
SCHEDULE 13G/A Apr 23, 2025
ARS Apr 17, 2025 ARS
DEFA14A Apr 17, 2025 DEFA14A
DEF 14A Apr 17, 2025 DEF 14A
PRE 14A Apr 7, 2025 PRE 14A
144 Mar 6, 2025
10-K Mar 5, 2025 10-K
8-K Mar 5, 2025 8-K
4 Jan 16, 2025 4
4 Jan 16, 2025 4
4 Jan 16, 2025 4
4 Jan 13, 2025 4
4 Jan 13, 2025 4
4 Jan 13, 2025 4
144 Jan 10, 2025
144 Jan 10, 2025
144 Jan 10, 2025
← Newer Page 4 of 34 · 848 filings Older →